Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Dalgleish

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
Expert Opinion on Biological Therapy|December 1, 2001
Immunotherapeutic and antitumour potential of thalidomide analoguesJ B Marriott, G Muller, D Stirling, et al.
AIDS (London, England)|October 6, 1999
The gp120 envelope of HIV-1 binds and presents peptides in a similar manner to human leukocyte antigenJ Sheikh, B Souberbielle, M Westby, et al.
British Journal of Cancer|August 22, 2002
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/BaxF Pettersson, A G Dalgleish, R P Bissonnette, et al.
Viral Immunology|March 25, 2000
HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell linesJ Sheikh, B Souberbielle, M Westby, et al.
The Medical Journal of Australia|September 3, 1983
Hepatocellular carcinoma associated with hepatitis B in a renal graft recipientA G Dalgleish, D J Tiller, J Horvath, et al.
AIDS Research and Human Retroviruses|July 1, 1994
Panel of anti-gp120 monoclonal antibodies reacts with same nuclear proteins in uninfected cells as those recognized by autoantibodies from patients with systemic lupus erythematosusL A Pinto, A G Dalgleish, N Sumar, et al.
British Journal of Cancer|December 10, 2009
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responsesW M Liu, D W Fowler, P Smith, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1995
AIDS: clinical and scientific issues past, present and futureA G Dalgleish, G J Moyle, P Easterbrook, et al.
AIDS (London, England)|November 1, 1995
The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigensM J Sheikh, J Ongrádi, B M Austen, et al.
Clinical and Experimental Immunology|January 1, 1992
HIV-induced deletion of antigen-specific T cell function is MHC restrictedF Manca, A Newell, M Valle, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
Expert Opinion on Biological Therapy|December 1, 2001
Immunotherapeutic and antitumour potential of thalidomide analoguesJ B Marriott, G Muller, D Stirling, et al.
AIDS (London, England)|October 6, 1999
The gp120 envelope of HIV-1 binds and presents peptides in a similar manner to human leukocyte antigenJ Sheikh, B Souberbielle, M Westby, et al.
British Journal of Cancer|August 22, 2002
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/BaxF Pettersson, A G Dalgleish, R P Bissonnette, et al.
Viral Immunology|March 25, 2000
HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell linesJ Sheikh, B Souberbielle, M Westby, et al.
The Medical Journal of Australia|September 3, 1983
Hepatocellular carcinoma associated with hepatitis B in a renal graft recipientA G Dalgleish, D J Tiller, J Horvath, et al.
AIDS Research and Human Retroviruses|July 1, 1994
Panel of anti-gp120 monoclonal antibodies reacts with same nuclear proteins in uninfected cells as those recognized by autoantibodies from patients with systemic lupus erythematosusL A Pinto, A G Dalgleish, N Sumar, et al.
British Journal of Cancer|December 10, 2009
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responsesW M Liu, D W Fowler, P Smith, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1995
AIDS: clinical and scientific issues past, present and futureA G Dalgleish, G J Moyle, P Easterbrook, et al.
AIDS (London, England)|November 1, 1995
The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigensM J Sheikh, J Ongrádi, B M Austen, et al.
Clinical and Experimental Immunology|January 1, 1992
HIV-induced deletion of antigen-specific T cell function is MHC restrictedF Manca, A Newell, M Valle, et al.
Pageof 23